British Society of Rheumatology

Abstract Objectives Mycophenolate mofetil (MMF) is routinely used in early diffuse cutaneous systemic sclerosis (dcSSc) but not in limited cutaneous […]

Abstract Objectives To examine contemporary trends in mortality due to granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in Europe.

Corresponding author details: Eva Mante Hoekstra, Department of Rheumatology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.

Abstract Objectives To assess the role of comorbidities measurements in interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).

Abstract Cardiovascular disease remains a leading cause of mortality in Systemic Sclerosis (SSc). This review summarises key mechanisms in the

Abstract Objectives Axial involvement in psoriatic arthritis (axPsA) is common but is more heterogeneous than classical axial spondyloarthritis (axSpA). Posterior

Abstract Objective To investigate the long-term safety and efficacy of tocilizumab, an interleukin-6 receptor inhibitor, in patients with adult-onset Still’s

Abstract Objectives We aimed to evaluate the effects of GLP-1 receptor agonists (GLP-1RA) on symptom burden and opioid use in

Abstract There are several pressing reasons to re-examine shingles and strategies for its prevention through vaccination. Firstly, the UK has

Abstract Objectives The aim of this study was to identify robust predictive markers which may help personalize tapering protocols, minimizing

Abstract Objective To evaluate the diagnostic yield of whole exome sequencing (WES) vs targeted gene panel (TGP) testing in patients

Abstract Objectives To investigate the relationship between maternal disease, anti-rheumatic treatment, autoantibody levels and fetal atrioventricular (AV) conduction. Methods A

Abstract Objectives To conduct data-driven sensitivity analyses to evaluate whether refined definitions of childhood-onset systemic lupus erythematosus (cSLE) treat-to-target goals

Abstract Objectives Tumor necrosis factor alpha inhibitors (TNFis) are effective biologic drugs for rheumatoid arthritis (RA), but their comparative efficacy

Abstract Objectives Several studies reported an association between Sjögren’s disease (SjD) and inclusion body myositis (IBM). However, the potential specificities

Abstract Objectives Increased work-related physical strain associates with higher subclinical joint inflammation in the rheumatoid arthritis(RA) at-risk phase of clinically

Abstract Objectives Cardiac involvements in idiopathic inflammatory myopathies (IIM) is rare but potentially severe. Anti-mitochondrial M2 antibody (AMA-M2) has been

This is a correction to: Alberto Floris, Riccardo Laconi, Sarra Chadli, Ahmed Laymouna, Mohamed Tharwat Hegazy, Yeliz Yagiz Ozogul, Yesim Ozguler,

Abstract Objective To stablish the predictive value of antiphospholipid antibody (aPL) negativization on recurrent thrombosis in thrombotic antiphospholipid syndrome (APS).

Abstract Objectives Complete renal response (CRR) is a primary goal in lupus nephritis (LN) management. We examined the prevalence and

Abstract Objectives Patient education is increasingly acknowledged as an important aspect of the management of systemic lupus erythematosus (SLE). The

Abstract Objective To assess efficacy of voclosporin from a retrospective, observational, clinical-practice-based, nationwide multicentre study of patients with lupus nephritis

Abstract Objectives Due to their non-specific clinical presentation and low prevalence, diagnostic delays are common in Takayasu arteritis (TA) and

Abstract Objective We investigated whether gradual clinical changes in RA patients diagnosed over two decades contributed to their improving outcomes

Abstract Objectives Polymyalgia rheumatica (PMR) is the second most frequent inflammatory rheumatic disease in older adults, after rheumatoid arthritis. Recommendations

Abstract Objectives The role of autoantibody-producing B-cells in connective tissue diseases (CTD) has recently been highlighted by the successful treatment

Abstract Objectives To determine the frequency of axial spondyloarthritis (axSpA) patients fulfilling the recently proposed Assessment of SpondyloArthritis International Society